You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Meaningful treatment outcomes in Alzheimer’s disease
  1. A Burns
  1. Department of Old Age Psychiatry, University of Manchester, Education & Research Centre, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK
  1. Correspondence to:
 Professor A S Burns;
 a_burns{at}man.ac.uk

https://doi.org/10.1136/jnnp.73.5.471

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Goal Attainment Scaling allows for problems identified by patients and carers to be the focus of treatment

    The explosion of interest in clinical trials for the treatment of the symptoms of Alzheimer’s disease has resulted in an industry developing instruments, which assess the disorder and the changes that can occur as a result of interventions.1 The ability to quantify phenomena is an essential prerequisite to measure the effects of any treatments.

    The questioning of the relevance of a purely cognitive approach to monitoring change in Alzheimer’s disease—that is, the understandable doubt as to the clinical relevance of, say, remembering eight as opposed …

    View Full Text

    Footnotes

    • Competing interests: AB receives honoria from parmaceutical companies involved in the development of drugs for people with Alzheimer’s disease

    Linked Articles